Similar articles

• ACP Journal Club. One or two 7.5-microg doses of MF59-adjuvanted influenza A (H1N1) 2009 vaccine was immunogenic in adults within 21 days.

  Granwehr B. Granwehr B. Ann Intern Med. 2010 Jan 19;152(2):JC1-8, JC1-9. doi: 10.7326/0003-4819-152-2-201001190-02008. Ann Intern Med. 2010. PMID: 20083823 No abstract available.
• A single dose of unadjuvanted novel 2009 H1N1 vaccine is immunogenic and well tolerated in young and elderly adults.

  Talaat KR, Greenberg ME, Lai MH, Hartel GF, Wichems CH, Rockman S, Jeanfreau RJ, Ghosh MR, Kabongo ML, Gittleson C, Karron RA. Talaat KR, et al. J Infect Dis. 2010 Nov 1;202(9):1327-37. doi: 10.1086/656601. J Infect Dis. 2010. PMID: 20874515 Clinical Trial.
• Response to a monovalent 2009 influenza A (H1N1) vaccine.

  Greenberg ME, Lai MH, Hartel GF, Wichems CH, Gittleson C, Bennet J, Dawson G, Hu W, Leggio C, Washington D, Basser RL. Greenberg ME, et al. N Engl J Med. 2009 Dec 17;361(25):2405-13. doi: 10.1056/NEJMoa0907413. Epub 2009 Sep 10. N Engl J Med. 2009. PMID: 19745216 Clinical Trial.
• AF03-adjuvanted and non-adjuvanted pandemic influenza A (H1N1) 2009 vaccines induce strong antibody responses in seasonal influenza vaccine-primed and unprimed mice.

  Caillet C, Piras F, Bernard MC, de Montfort A, Boudet F, Vogel FR, Hoffenbach A, Moste C, Kusters I. Caillet C, et al. Vaccine. 2010 Apr 19;28(18):3076-9. doi: 10.1016/j.vaccine.2010.02.050. Epub 2010 Mar 1. Vaccine. 2010. PMID: 20193791
• Panvax(®): a monovalent inactivated unadjuvanted vaccine against pandemic influenza A (H1N1) 2009.

  McVernon J, Nolan T. McVernon J, et al. Expert Rev Vaccines. 2011 Jan;10(1):35-43. doi: 10.1586/erv.10.143. Expert Rev Vaccines. 2011. PMID: 21162618 Review.